Trigeminal postherpetic neuralgia responsive to treatment with capsaicin 8 % topical patch: A case report

Journal of Headache and Pain

Volumn 13, Issue 7, 2012, Pages 587-589

  Sayanlar, Jennifer ^a   Guleyupoglu, Nilufer ^a   Portenoy, Russell ^a   Ashina, Sait ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CAPSAICIN; DULOXETINE; MORPHINE SULFATE; OXYMORPHONE; PREGABALIN; TAPENTADOL; VALACICLOVIR;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; HERPES ZOSTER ENCEPHALITIS; HUMAN; MALE; PAIN ASSESSMENT; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; SYMPTOM; TREATMENT OUTCOME; TRIGEMINUS NEURALGIA;

ADMINISTRATION, TOPICAL; CAPSAICIN; FEMALE; HUMANS; MIDDLE AGED; NEURALGIA, POSTHERPETIC; SENSORY SYSTEM AGENTS; TRIGEMINAL NEURALGIA;

EID: 84870352325     PISSN: 11292369     EISSN: 11292377     Source Type: Journal    
DOI: 10.1007/s10194-012-0467-0     Document Type: Article

References (24)

1. Kost RG, Straus SE (1996) Postherpetic neuralgia-pathogenesis, treatment, and prevention. N Engl J Med 335:32-42
2. Cunningham AL, Dworkin RH (2000) The management of postherpetic neuralgia. BMJ 321:778-779
3. Jung BF, Johnson RW, Griffin DR et al (2004) Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology 62:1545-1551
4. Opstelten W, Mauritz JW, de Wit NJ et al (2002) Herpes zoster and postherpetic neuralgia: Incidence and risk indicators using a general practice research database. Fam Pract 19:471-475
5. Nagasako EM, Johnson RW, Griffin DR et al (2002) Rash severity in herpes zoster: Correlates and relationship to postherpetic neuralgia. J Am Acad Dermatol 46:834-839
6. Brown GR (1976) Herpes zoster: Correlation of age, sex, distribution, neuralgia, and associated disorders. South Med J 69:576-578
7. Goh CL, Khoo L (1997) A retrospective study of the clinical presentation and outcome of herpes zoster in a tertiary dermatology outpatient referral clinic. Int J Dermatol 36:667-672
8. Dubinsky RM, Kabbani H, El-Chami Z et al (2004) Practice parameter: Treatment of postherpetic neuralgia: An evidencebased report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 63:959-965
9. Dworkin RH, Johnson RW, Breuer J et al (2007) Recommendations for the management of herpes zoster. Clin Infect Dis 44:S1-S26
10. Hempenstall K, Nurmikko TJ, Johnson RW et al (2005) Analgesic therapy in postherpetic neuralgia: A quantitative systematic review. PLoS Med 2:e164
11. Edelsberg JS, Lord C, Oster G (2011) Systematic review and meta-analysis of efficacy, safety, and tolerability data from randomized controlled trials of drugs used to treat postherpetic neuralgia. Ann Pharmacother 45:1483-1490
12. Haythornthwaite JA, Benrud-Larson LM (2001) Psychological assessment and treatment of patients with neuropathic pain. Curr Pain Headache Rep 5:124-129
13. Wu CL, Raja SN (2008) An update on the treatment of postherpetic neuralgia. J Pain 9:S19-S30
14. Watson CP, Tyler KL, Bickers DR et al (1993) A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin Ther 15:510-526
15. Backonja M, Wallace MS, Blonsky ER et al (2008) NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: A randomised, double-blind study. Lancet Neurol 7:1106-1112
16. Irving GA, Backonja MM, Dunteman E et al (2011) A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia. Pain Med 12:99-109
17. Backonja MM, Malan TP, Vanhove GF et al (2010) NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: A randomized, double-blind, controlled study with an open-label extension. Pain Med 11:600-608
18. Papoiu AD, Yosipovitch G (2010) Topical capsaicin. The fire of a 'hot' medicine is reignited. Expert Opin Pharmacother 11:1359-1371
19. Anand P, Bley K (2011) Topical capsaicin for pain management: Therapeutic potential and mechanisms of action of the new highconcentration capsaicin 8% patch. Br J Anaesth 107:490-502
20. Alawi K, Keeble J (2010) The paradoxical role of the transient receptor potential vanilloid 1 receptor in inflammation. Pharmacol Ther 125:181-195
21. Polak JM, Bloom SR (1981) The peripheral substance P-ergic system. Peptides 2:133-148
22. Kennedy WR, Vanhove GF, Lu SP et al (2010) A randomized, controlled, open-label study of the long-term effects of NGX-4010, a high-concentration capsaicin patch, on epidermal nerve fiber density and sensory function in healthy volunteers. J Pain 11:579-587
23. Malmberg AB, Mizisin AP, Calcutt NA et al (2004) Reduced heat sensitivity and epidermal nerve fiber immunostaining following single applications of a high-concentration capsaicin patch. Pain 111:360-367
24. Holzer P (2008) The pharmacological challenge to tame the transient receptor potential vanilloid-1 (TRPV1) nocisensor. Br J Pharmacol 155:1145-1162